The dispersed market-implied odds for the next Claude Opus release, with September 21 holding the highest at 33.1% and a 20% chance of no launch by month-end, stem primarily from the absence of any official Anthropic confirmation on timing. Traders are weighing typical AI development cycles against competitive pressures from models like GPT-5 and Gemini updates, where demonstrated capabilities and internal benchmarks often dictate schedules. This creates a wide field because product timelines frequently slip due to safety evaluations or scaling challenges for large language models. Key near-term catalysts include potential announcements at industry events or earnings updates that could shift sentiment toward a specific date or delay.